Resectable Rectal Cancer at Clinical Stage T1-2, N0: Surgical Management

This protocol addresses rectal cancer that is appropriate for surgical resection, confirmed at clinical stage T1-2, N0 by pelvic MRI or endorectal ultrasound.

Clinical scenario Rectal cancer appropriate for resection at clinical stage T1-2, N0. Accurate staging relies on pelvic MRI (preferred) or endorectal ultrasound to confirm lymph node-negative, early-stage disease before surgery.

Treatment approach (summary) Management centres on a transabdominal surgical approach — the full operative technique and any additional considerations are detailed in the complete protocol.

Instant Access to Structured Evidence-Based Regimens

References

Rectal cancer appropriate for resection
T1–2, N0
T1–2, N0 should be based on assessment of pelvic MRI (preferred) or endorectal ultrasound.
Transabdominal resection
In transabdominal resections, TME is recommended.

View source ↗